References
- Wang CC, Rook GA. Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology. 1998;93:307–13.
- Kimura I, Ohnoshi T, Yasuhara S, Sugiyama M, Urabe Y. Immunotherapy in human lung cancer using Streptococcus agent OK-432. Cancer. 1976;37:2201–3.
- Inui S, Asada H, Wataya-Kaneda M, Miyamoto T, Itami S, Yoshikawa K. OK-432 therapy for recalcitrant warts. J Dermatol. 1997;24:301–5.
- Fujimoto T, Duda RB, Szilvasi A, Chen X, Mai M, O’Donnell MA. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state. J Immunol. 1997;158:5619–26.
- Matsuoka H, Wakasugi H, Sadamoto K, et al. Development of OK-432 ointment and advantage in immunomodulatory effect by OK-432 ointment. Biotherapy. 1997;11:587-9(in Japanese).
- Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol (Stockh). 1989;144(suppl): 13–14.
- Reitamo S, Wollenberg A, Schopf E, Perrot JL, Marks R, Ruzicka T, et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol. 2000;136:999–1006.
- Banieghbal B, Davies MR. Guideline for the successful treatment of lymphangioma with OK-432. Eur J Pediatr Surg. 2003;13:103–7.
- Saito H, Watanabe T, Tomioka H, Sato K, Kitagawa T. Enhanced resistance to Pseudomonas aeruginosa infection in mice pretreated with OK-432. Hiroshima J Med Sci. 1983;32:235–9.
- Enomoto M, Shirakawa T, Dake Y, et al. Preliminary trial for atopy intervention with microbe extracts. Clin Immunol. 1999;32:454-9(in Japanese).
- Horiuchi Y, Bae S-J, Katayama I, Nishioka K. Therapeutic effects of streptococcal preparation OK-432 on atopic dermatitis-like lesions in NC/Nga mice: possible shift from a Th2- to Th1-predominance. J Dermatol Sci. 2004;35:187–97.
- Okamoto M, Ohe G, Oshikawa T, Furuichi S, Nishikawa H, Tano T, et al. Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Strepto- coccus. Cancer Immunol Immunother. 2001;50:408–16.